Cloaking antibodies are prevalent in

Humans Burkholderia Infections / immunology Antibodies, Bacterial / blood Burkholderia cepacia complex / immunology Cystic Fibrosis / complications Female Male Adult Lipopolysaccharides / immunology Blood Bactericidal Activity Middle Aged Bacteremia / microbiology
Burkholderia cepacia complex antibody cepacia syndrome complement cystic fibrosis serum resistance

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 02 05 2024
accepted: 12 07 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

The Twelve We found that several of the Cloaking antibodies are prevalent in patients with

Identifiants

DOI: 10.3389/fcimb.2024.1426773 PMID: 39193503 PMC: PMC11347948
pubmed: 39193503
doi: 10.3389/fcimb.2024.1426773
pmc: PMC11347948
doi:

Substances chimiques

Antibodies, Bacterial 0
Lipopolysaccharides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1426773

Informations de copyright

Copyright © 2024 Pham, Tan, Ledger, Smith, Reid, Burr, Chambers and Wells.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that this study received funding from Cystic Fibrosis Research Limited (CFRL). AP was supported by a Research Fellowship from The Common Good, an initiative of The Prince Charles Hospital Foundation. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

Auteurs

Amy Pham (A)

Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD, Australia.

Kellynn K Y Tan (KKY)

Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.

Emma L Ledger (EL)

Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.

Daniel J Smith (DJ)

Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
The Adult Cystic Fibrosis Centre and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia.

David W Reid (DW)

The Adult Cystic Fibrosis Centre and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.
QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Lucy Burr (L)

Department of Respiratory Medicine, Mater Health, South Brisbane, QLD, Australia.
Mater Research, University of Queensland, Brisbane, QLD, Australia.

Daniel C Chambers (DC)

Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD, Australia.

Timothy J Wells (TJ)

Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cloaking antibodies are prevalent in
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Burkholderia › Cloaking antibodies are prevalent in
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antibactériens › Cloaking antibodies are prevalent in
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Burkholderia cepacia complex › Cloaking antibodies are prevalent in
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies néonatales › Mucoviscidose › Cloaking antibodies are prevalent in
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Cloaking antibodies are prevalent in
questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Toxines bactériennes › Endotoxines › Lipopolysaccharides › Cloaking antibodies are prevalent in
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité innée › Activité bactéricide du sang › Cloaking antibodies are prevalent in
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Cloaking antibodies are prevalent in
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Sepsie › Bactériémie › Cloaking antibodies are prevalent in